| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1352146 | 6480464 | epigallocatechin gallate inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA]; more ... | CTD | PMID:20471814 |
| (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:1352146 | 6480464 | epigallocatechin gallate results in decreased expression of MT2A mRNA | CTD | PMID:20471814 |
| (S)-nicotine | multiple interactions | ISO | RGD:1617617 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of MT2 mRNA; more ... | CTD | PMID:20230807 |
| 1,4-phenylenediamine | increases expression | ISO | RGD:1352146 | 6480464 | 4-phenylenediamine results in increased expression of MT2A mRNA | CTD | PMID:16314067 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:1352146 | 6480464 | Dinitrochlorobenzene results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | ISO | RGD:1617617 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of MT2 mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:1617617 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of MT2 mRNA; more ... | CTD | PMID:20230807 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1617617 | 6480464 | Ethinyl Estradiol results in increased expression of MT2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1617617 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MT2 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases expression | ISO | RGD:1352146 | 6480464 | Estradiol results in increased expression of MT2A mRNA | CTD | PMID:19153601 more ... |
| 17beta-estradiol | decreases expression | ISO | RGD:1352146 | 6480464 | Estradiol results in decreased expression of MT2A mRNA | CTD | PMID:17982697 PMID:23019147 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1352146 | 6480464 | [Parathion co-treated with Estradiol] results in decreased expression of MT2A mRNA | CTD | PMID:17982697 |
| 17beta-estradiol | decreases expression | ISO | RGD:1352146 | 6480464 | Estradiol results in decreased expression of MT2A mRNA | CTD | PMID:23019147 |
| 17beta-estradiol | increases expression | ISO | RGD:1352146 | 6480464 | Estradiol results in increased expression of MT2A mRNA | CTD | PMID:16202921 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1352146 | 6480464 | Estradiol results in increased expression of MT2A mRNA | CTD | PMID:19153601 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1352146 | 6480464 | Estradiol results in increased expression of MT2A mRNA | CTD | PMID:16202921 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1352146 | 6480464 | Estradiol results in increased expression of MT2A mRNA | CTD | PMID:19619570 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1352146 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MT2A mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases expression | ISO | RGD:1352146 | 6480464 | Estradiol results in increased expression of MT2A mRNA | CTD | PMID:20945400 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1352146 | 6480464 | [Estradiol co-treated with ESR2 protein] results in increased expression of MT2 mRNA | CTD | PMID:12399409 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | RGD:1352146 | 6480464 | Dihydrotestosterone results in decreased expression of MT2A mRNA | CTD | PMID:20945400 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1617617 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MT2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1352146 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MT2A mRNA | CTD | PMID:11489354 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1352146 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MT2A mRNA | CTD | PMID:16039398 PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1617617 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MT2 mRNA | CTD | PMID:18372398 PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MT2A mRNA | CTD | PMID:11521753 PMID:18465118 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1352146 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MT2A mRNA | CTD | PMID:11489354 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1617617 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MT2 mRNA | CTD | PMID:18295293 PMID:18691609 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MT2A mRNA | CTD | PMID:18465118 PMID:11521753 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1352146 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MT2A mRNA | CTD | PMID:20106945 PMID:11489354 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1352146 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MT2A mRNA | CTD | PMID:19619570 PMID:16039398 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1617617 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MT2 mRNA | CTD | PMID:18691609 PMID:18295293 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1352146 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MT2A mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1617617 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MT2 mRNA | CTD | PMID:15667827 PMID:18372398 |
| 2,4,6-trinitrotoluene | increases expression | ISO | RGD:1352146 | 6480464 | Trinitrotoluene results in increased expression of MT2A mRNA | CTD | PMID:11409192 |
| 2-butoxyethanol | increases expression | ISO | RGD:1617617 | 6480464 | n-butoxyethanol results in increased expression of MT2 mRNA | CTD | PMID:19812364 |
| 2-methylcholine | affects expression | ISO | RGD:1352146 | 6480464 | beta-methylcholine affects the expression of MT2A mRNA | CTD | PMID:21179406 |
| 2-nitrofluorene | decreases expression | EXP | | 6480464 | 2-nitrofluorene results in decreased expression of MT2 mRNA | CTD | PMID:14600272 |
| 2-nitrofluorene | decreases expression | EXP | | 6480464 | 2-nitrofluorene results in decreased expression of MT2A mRNA | CTD | PMID:15890375 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1617617 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MT2 mRNA; more ... | CTD | PMID:15306638 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1617617 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MT2 mRNA | CTD | PMID:16054899 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of MT2A mRNA | CTD | PMID:19162173 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MT2 mRNA | CTD | PMID:14600272 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MT2A mRNA | CTD | PMID:15890375 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1617617 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of MT2 mRNA | CTD | PMID:19191707 |
| 4-methylaminophenol | increases expression | ISO | RGD:1352146 | 6480464 | metol results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1352146 | 6480464 | decitabine results in increased expression of MT2A mRNA | CTD | PMID:19151715 |
| actinomycin D | multiple interactions | ISO | RGD:1352146 | 6480464 | Dactinomycin inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA] | CTD | PMID:17234632 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of MT2 mRNA | CTD | PMID:14600272 |
| aflatoxin B1 | increases expression | ISO | RGD:1352146 | 6480464 | Aflatoxin B1 results in increased expression of MT2A mRNA | CTD | PMID:21641981 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of MT2A mRNA | CTD | PMID:15890375 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MT2A mRNA | CTD | PMID:16483693 |
| arachidonic acid | multiple interactions | ISO | RGD:1352146 | 6480464 | Arachidonic Acid promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA] | CTD | PMID:12566070 |
| arsenic atom | decreases expression | ISO | RGD:1352146 | 6480464 | Arsenic results in decreased expression of MT2A mRNA | CTD | PMID:17637929 |
| arsenic atom | increases expression | ISO | RGD:1352146 | 6480464 | Arsenic results in increased expression of MT2A mRNA | CTD | PMID:17409696 |
| arsenic atom | affects response to substance | ISO | RGD:1617617 | 6480464 | MT2 protein affects the susceptibility to Arsenic | CTD | PMID:10828279 |
| arsenic atom | increases expression | ISO | RGD:1617617 | 6480464 | Arsenic results in increased expression of MT2 mRNA | CTD | PMID:19654921 |
| arsenite(3-) | increases expression | ISO | RGD:1617617 | 6480464 | arsenite results in increased expression of MT2 mRNA | CTD | PMID:15894712 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of MT2A mRNA | CTD | PMID:1493605 |
| arsenite(3-) | multiple interactions | ISO | RGD:1617617 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of MT2 mRNA | CTD | PMID:15894712 |
| atrazine | multiple interactions | ISO | RGD:1352146 | 6480464 | Atrazine promotes the reaction [arsenic trioxide results in increased expression of MT2A mRNA] | CTD | PMID:11678611 |
| benomyl | increases expression | EXP | | 6480464 | Benomyl results in increased expression of MT2A mRNA | CTD | PMID:15885261 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1352146 | 6480464 | Benzo(a)pyrene results in decreased expression of MT2A mRNA | CTD | PMID:20106945 PMID:20064835 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1352146 | 6480464 | [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] results in increased expression of MT2A mRNA | CTD | PMID:17690111 |
| benzo[a]pyrene | increases expression | ISO | RGD:1352146 | 6480464 | Benzo(a)pyrene results in increased expression of MT2A mRNA | CTD | PMID:21632981 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:1617617 | 6480464 | Benzo(a)pyrene results in increased expression of MT2 mRNA | CTD | PMID:15894712 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:1352146 | 6480464 | Benzo(a)pyrene results in increased expression of MT2A mRNA | CTD | PMID:21871943 PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:1617617 | 6480464 | Benzo(a)pyrene results in increased expression of MT2 mRNA | CTD | PMID:15894712 PMID:21569818 |
| benzo[a]pyrene | increases expression | ISO | RGD:1352146 | 6480464 | Benzo(a)pyrene results in increased expression of MT2A mRNA | CTD | PMID:21871943 |
| benzo[a]pyrene | increases expression | ISO | RGD:1617617 | 6480464 | Benzo(a)pyrene results in increased expression of MT2 mRNA | CTD | PMID:21569818 PMID:15894712 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1617617 | 6480464 | Benzo(a)pyrene results in decreased expression of MT2 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1352146 | 6480464 | Benzo(a)pyrene results in decreased expression of MT2A mRNA | CTD | PMID:20064835 PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:1617617 | 6480464 | Benzo(a)pyrene results in increased expression of MT2 mRNA | CTD | PMID:15894712 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1617617 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of MT2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1617617 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of MT2 mRNA | CTD | PMID:15894712 |
| benzo[d]isothiazol-3-one | increases expression | ISO | RGD:1352146 | 6480464 | 1,2-benzisothiazoline-3-one results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| benzoic acid | increases expression | ISO | RGD:1352146 | 6480464 | Benzoic Acid results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| biochanin A | increases expression | ISO | RGD:1352146 | 6480464 | biochanin A results in increased expression of MT2A mRNA | CTD | PMID:10656621 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1617617 | 6480464 | Diethylhexyl Phthalate results in increased expression of MT2 mRNA | CTD | PMID:15294341 PMID:19850644 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1617617 | 6480464 | Diethylhexyl Phthalate results in increased expression of MT2 mRNA | CTD | PMID:19850644 PMID:15294341 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1617617 | 6480464 | Diethylhexyl Phthalate results in increased expression of MT2 protein | CTD | PMID:15294341 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:1617617 | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of MT2 mRNA] | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1617617 | 6480464 | Diethylhexyl Phthalate results in decreased expression of MT2 mRNA | CTD | PMID:15294341 |
| bis(2-ethylhexyl) phthalate | affects expression | ISO | RGD:1617617 | 6480464 | Diethylhexyl Phthalate affects the expression of MT2 mRNA | CTD | PMID:19850644 |
| bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of MT2A mRNA | CTD | PMID:15056800 |
| budesonide | increases expression | ISO | RGD:1352146 | 6480464 | Budesonide results in increased expression of MT2A mRNA | CTD | PMID:9973176 |
| budesonide | multiple interactions | ISO | RGD:1352146 | 6480464 | Terbutaline affects the reaction [Budesonide results in increased expression of MT2A mRNA] | CTD | PMID:9973176 |
| cadmium atom | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:17409708 more ... |
| cadmium atom | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:12716893 more ... |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:11430474 more ... |
| cadmium atom | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:12716893 more ... |
| cadmium atom | affects binding | ISO | RGD:1617617 | 6480464 | MT2 protein binds to Cadmium | CTD | PMID:22001350 |
| cadmium atom | multiple interactions | ISO | RGD:1617617 | 6480464 | [ferric nitrilotriacetate co-treated with Hydrogen Peroxide] inhibits the reaction [MT2 protein binds to Cadmium] | CTD | PMID:22001350 |
| cadmium atom | decreases response to substance | ISO | RGD:1352146 | 6480464 | MT2A protein results in decreased susceptibility to Cadmium | CTD | PMID:19433272 |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:11430474 more ... |
| cadmium atom | increases abundance | ISO | RGD:1352146 | 6480464 | MT2A promoter polymorphism results in increased abundance of Cadmium | CTD | PMID:20303360 |
| cadmium atom | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:17409696 more ... |
| cadmium atom | increases expression | ISO | RGD:1617617 | 6480464 | Cadmium results in increased expression of MT2 mRNA | CTD | PMID:10605938 |
| cadmium atom | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:17409696 more ... |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of MT2A | CTD | PMID:12974610 |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:11430474 more ... |
| cadmium atom | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:15967203 more ... |
| cadmium atom | decreases response to substance | EXP | | 6480464 | MT2A protein results in decreased susceptibility to Cadmium | CTD | PMID:17443291 |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:17327699 more ... |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of MT2A protein | CTD | PMID:17443291 |
| cadmium atom | affects expression | EXP | | 6480464 | Cadmium affects the expression of MT2A mRNA; more ... | CTD | PMID:12140172 |
| cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of MT2A mRNA | CTD | PMID:14694715 |
| cadmium atom | multiple interactions | ISO | RGD:1352146 | 6480464 | chromium hexavalent ion inhibits the reaction [Cadmium results in increased expression of MT2A mRNA] | CTD | PMID:12716893 |
| cadmium atom | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium results in increased expression of MT2A mRNA | CTD | PMID:17409708 more ... |
| cadmium atom | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium results in increased expression of MT2A protein | CTD | PMID:15664440 |
| cadmium atom | affects binding | ISO | RGD:1352146 | 6480464 | Cadmium binds to MT2A protein | CTD | PMID:15698955 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [Cadmium results in increased expression of MT2 mRNA] | CTD | PMID:16226777 |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of MT2 mRNA | CTD | PMID:16226777 |
| cadmium atom | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 protein co-treated with MT2 protein] inhibits the reaction [Cadmium results in increased phosphorylation of MAPK8 protein]; more ... | CTD | PMID:16568437 |
| cadmium dichloride | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:17409708 more ... |
| cadmium dichloride | increases expression | ISO | RGD:1617617 | 6480464 | Cadmium Chloride results in increased expression of MT2 mRNA | CTD | PMID:11171528 more ... |
| cadmium dichloride | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 gene mutant form co-treated with MT2 gene mutant form] inhibits the reaction [Cadmium Chloride results in increased expression of ABCC2]; more ... | CTD | PMID:22914987 |
| cadmium dichloride | increases expression | ISO | RGD:1617617 | 6480464 | Cadmium Chloride results in increased expression of MT2 mRNA | CTD | PMID:11171528 more ... |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:17327699 more ... |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:17327699 more ... |
| cadmium dichloride | decreases expression | ISO | RGD:1352146 | 6480464 | Cadmium Chloride results in decreased expression of MT2A mRNA | CTD | PMID:19426795 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:17327699 PMID:19096765 |
| cadmium dichloride | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:11678604 more ... |
| cadmium dichloride | increases expression | ISO | RGD:1617617 | 6480464 | Cadmium Chloride results in increased expression of MT2 mRNA | CTD | PMID:11171528 more ... |
| cadmium dichloride | multiple interactions | ISO | RGD:1617617 | 6480464 | zinc chloride promotes the reaction [Cadmium Chloride results in increased expression of MT2 mRNA] | CTD | PMID:16842966 |
| cadmium dichloride | multiple interactions | ISO | RGD:1617617 | 6480464 | MT2 gene mutant form promotes the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA] | CTD | PMID:11051100 |
| cadmium dichloride | multiple interactions | ISO | RGD:1617617 | 6480464 | MT2 affects the reaction [Cadmium Chloride results in decreased expression of BRCA2 mRNA]; more ... | CTD | PMID:11958953 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:19096765 PMID:17327699 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [Cadmium Chloride results in increased expression of MT2A] | CTD | PMID:20096345 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | lead acetate promotes the reaction [Cadmium Chloride results in increased expression of MT2A mRNA] | CTD | PMID:19096765 |
| cadmium dichloride | increases expression | ISO | RGD:1617617 | 6480464 | Cadmium Chloride results in increased expression of MT2 mRNA | CTD | PMID:17499415 more ... |
| cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of MT2A mRNA | CTD | PMID:22110744 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of MT2A | CTD | PMID:20096345 |
| cadmium dichloride | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:16402917 more ... |
| cadmium dichloride | increases expression | ISO | RGD:1617617 | 6480464 | Cadmium Chloride results in increased expression of MT2 mRNA | CTD | PMID:15081267 more ... |
| cadmium dichloride | decreases response to substance | ISO | RGD:1352146 | 6480464 | MT2A protein results in decreased susceptibility to Cadmium Chloride | CTD | PMID:7729958 PMID:16636651 |
| cadmium dichloride | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:17409708 more ... |
| cadmium dichloride | decreases response to substance | EXP | | 6480464 | MT2A protein results in decreased susceptibility to Cadmium Chloride | CTD | PMID:17443291 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of MT2A protein | CTD | PMID:17443291 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:17327699 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:15499971 |
| cadmium dichloride | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium Chloride results in increased expression of MT2A protein | CTD | PMID:15788722 |
| cadmium dichloride | decreases response to substance | ISO | RGD:1352146 | 6480464 | MT2A protein results in decreased susceptibility to Cadmium Chloride | CTD | PMID:16636651 PMID:7729958 |
| cadmium dichloride | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:16402917 more ... |
| cadmium dichloride | increases response to substance | ISO | RGD:1617617 | 6480464 | MT2 protein results in increased susceptibility to Cadmium Chloride | CTD | PMID:16150881 |
| cadmium dichloride | multiple interactions | ISO | RGD:1617617 | 6480464 | MT2 affects the susceptibility to [Cadmium Chloride co-treated with sodium arsenite] | CTD | PMID:10924798 |
| cadmium dichloride | increases expression | ISO | RGD:1617617 | 6480464 | Cadmium Chloride results in increased expression of MT2 protein | CTD | PMID:15964310 |
| cadmium dichloride | increases expression | ISO | RGD:1617617 | 6480464 | Cadmium Chloride results in increased expression of MT2 mRNA | CTD | PMID:11171528 |
| cadmium dichloride | multiple interactions | ISO | RGD:1352146 | 6480464 | Cadmium Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of MT2A mRNA] | CTD | PMID:9138684 |
| cadmium dichloride | increases expression | ISO | RGD:1352146 | 6480464 | Cadmium Chloride results in increased expression of MT2A mRNA | CTD | PMID:11678604 more ... |
| cadmium sulfate | increases expression | ISO | RGD:1352146 | 6480464 | cadmium sulfate results in increased expression of MT2A mRNA | CTD | PMID:10362023 PMID:21783983 |
| cadmium sulfate | multiple interactions | ISO | RGD:1617617 | 6480464 | cadmium sulfate affects the reaction [MTF1 affects the expression of MT2 mRNA] | CTD | PMID:16221973 |
| cadmium sulfate | increases expression | ISO | RGD:1352146 | 6480464 | cadmium sulfate results in increased expression of MT2A mRNA | CTD | PMID:21783983 |
| cadmium sulfate | decreases expression | ISO | RGD:1617617 | 6480464 | cadmium sulfate results in decreased expression of MT2 mRNA | CTD | PMID:19274763 |
| caffeine | multiple interactions | ISO | RGD:1617617 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of MT2 mRNA; more ... | CTD | PMID:20230807 |
| carmustine | affects response to substance | ISO | RGD:1352146 | 6480464 | MT2A mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| carmustine | affects response to substance | EXP | | 6480464 | MT2 protein affects the susceptibility to Carmustine | CTD | PMID:18528683 |
| carmustine | multiple interactions | EXP | | 6480464 | MT2 protein inhibits the reaction [Carmustine results in increased expression of TNF protein]; more ... | CTD | PMID:18528683 |
| cerium trichloride | increases expression | ISO | RGD:1617617 | 6480464 | cerous chloride results in increased expression of MT2 protein | CTD | PMID:15964310 |
| cerium trichloride | multiple interactions | ISO | RGD:1617617 | 6480464 | cerous chloride promotes the reaction [Zinc binds to MT2 protein] | CTD | PMID:16204935 |
| chloroprene | increases expression | ISO | RGD:1617617 | 6480464 | Chloroprene results in increased expression of MT2 mRNA | CTD | PMID:23125180 |
| cholesterol | multiple interactions | ISO | RGD:1617617 | 6480464 | [Cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of MT2 mRNA | CTD | PMID:22129739 |
| choline | multiple interactions | ISO | RGD:1617617 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MT2 mRNA | CTD | PMID:20938992 |
| chromium(6+) | multiple interactions | ISO | RGD:1352146 | 6480464 | chromium hexavalent ion inhibits the reaction [Zinc results in increased expression of MT2A mRNA]; more ... | CTD | PMID:12716893 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:1617617 | 6480464 | Ciguatoxins affects the expression of MT2 mRNA | CTD | PMID:18353800 |
| cisplatin | increases response to substance | ISO | RGD:1617617 | 6480464 | MT2 protein results in increased susceptibility to Cisplatin | CTD | PMID:16150881 |
| cisplatin | decreases response to substance | ISO | RGD:1352146 | 6480464 | MT2A protein results in decreased susceptibility to Cisplatin | CTD | PMID:16394183 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of MT2A mRNA | CTD | PMID:22023808 |
| cisplatin | increases expression | ISO | RGD:1352146 | 6480464 | Cisplatin results in increased expression of MT2A mRNA | CTD | PMID:12680227 |
| clofibrate | increases expression | ISO | RGD:1617617 | 6480464 | Clofibrate results in increased expression of MT2 mRNA | CTD | PMID:11356909 |
| clofibrate | multiple interactions | ISO | RGD:1617617 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of MT2 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | decreases expression | ISO | RGD:1617617 | 6480464 | Clofibrate results in decreased expression of MT2 mRNA | CTD | PMID:17585979 |
| cobalt atom | increases expression | ISO | RGD:1352146 | 6480464 | Cobalt results in increased expression of MT2A mRNA | CTD | PMID:14971665 |
| cobalt dichloride | increases expression | ISO | RGD:1352146 | 6480464 | cobaltous chloride results in increased expression of MT2A mRNA | CTD | PMID:19376846 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride deficiency results in increased expression of MT2A mRNA | CTD | PMID:17706837 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of MT2A mRNA | CTD | PMID:19278353 |
| cobalt dichloride | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of MT2A mRNA | CTD | PMID:19278353 |
| cobalt(2+) sulfate | increases expression | ISO | RGD:1352146 | 6480464 | cobalt sulfate results in increased expression of MT2A mRNA | CTD | PMID:10362023 |
| copper atom | multiple interactions | ISO | RGD:1617617 | 6480464 | [diamsar chelate results in decreased abundance of Copper] which affects the expression of MT2 mRNA | CTD | PMID:2231026 |
| copper atom | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 protein co-treated with MT2 protein] affects the susceptibility to Copper; more ... | CTD | PMID:14627437 |
| copper atom | increases expression | ISO | RGD:1617617 | 6480464 | Copper results in increased expression of MT2 mRNA | CTD | PMID:17205981 PMID:2231026 |
| copper atom | increases expression | ISO | RGD:1617617 | 6480464 | Copper results in increased expression of MT2 protein | CTD | PMID:17205981 |
| copper atom | increases expression | ISO | RGD:1617617 | 6480464 | Copper results in increased expression of MT2 mRNA | CTD | PMID:2231026 PMID:17205981 |
| copper atom | increases expression | ISO | RGD:1352146 | 6480464 | Copper results in increased expression of MT2 mRNA | CTD | PMID:16629173 |
| copper atom | multiple interactions | ISO | RGD:1352146 | 6480464 | [MT1 protein co-treated with MT2 protein] affects the reaction [Copper results in increased expression of ATP5F1 mRNA]; more ... | CTD | PMID:16629173 |
| copper atom | multiple interactions | ISO | RGD:1352146 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of MT2A mRNA | CTD | PMID:20971185 |
| copper atom | affects expression | EXP | | 6480464 | Copper affects the expression of MT2A mRNA; more ... | CTD | PMID:12140172 |
| copper atom | increases expression | ISO | RGD:1352146 | 6480464 | Copper results in increased expression of MT2A mRNA | CTD | PMID:17409696 |
| copper atom | increases expression | ISO | RGD:1617617 | 6480464 | Copper results in increased expression of MT2 mRNA | CTD | PMID:2231026 |
| copper(0) | multiple interactions | ISO | RGD:1617617 | 6480464 | [diamsar chelate results in decreased abundance of Copper] which affects the expression of MT2 mRNA | CTD | PMID:2231026 |
| copper(0) | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 protein co-treated with MT2 protein] affects the susceptibility to Copper; more ... | CTD | PMID:14627437 |
| copper(0) | increases expression | ISO | RGD:1617617 | 6480464 | Copper results in increased expression of MT2 mRNA | CTD | PMID:17205981 PMID:2231026 |
| copper(0) | increases expression | ISO | RGD:1617617 | 6480464 | Copper results in increased expression of MT2 protein | CTD | PMID:17205981 |
| copper(0) | increases expression | ISO | RGD:1617617 | 6480464 | Copper results in increased expression of MT2 mRNA | CTD | PMID:2231026 PMID:17205981 |
| copper(0) | increases expression | ISO | RGD:1352146 | 6480464 | Copper results in increased expression of MT2 mRNA | CTD | PMID:16629173 |
| copper(0) | multiple interactions | ISO | RGD:1352146 | 6480464 | [MT1 protein co-treated with MT2 protein] affects the reaction [Copper results in increased expression of ATP5F1 mRNA]; more ... | CTD | PMID:16629173 |
| copper(0) | multiple interactions | ISO | RGD:1352146 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of MT2A mRNA | CTD | PMID:20971185 |
| copper(0) | affects expression | EXP | | 6480464 | Copper affects the expression of MT2A mRNA; more ... | CTD | PMID:12140172 |
| copper(0) | increases expression | ISO | RGD:1352146 | 6480464 | Copper results in increased expression of MT2A mRNA | CTD | PMID:17409696 |
| copper(0) | increases expression | ISO | RGD:1617617 | 6480464 | Copper results in increased expression of MT2 mRNA | CTD | PMID:2231026 |
| copper(2+) sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Copper Sulfate results in increased expression of MT2A mRNA | CTD | PMID:10362023 more ... |
| copper(2+) sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Copper Sulfate results in increased expression of MT2A mRNA | CTD | PMID:16283523 more ... |
| copper(2+) sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Copper Sulfate results in increased expression of MT2A mRNA | CTD | PMID:20599845 more ... |
| copper(2+) sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Copper Sulfate results in increased expression of MT2A mRNA | CTD | PMID:20599845 |
| copper(II) chloride | multiple interactions | ISO | RGD:1352146 | 6480464 | cupric chloride promotes the reaction [Disulfiram results in increased expression of MT2A mRNA] | CTD | PMID:19789329 |
| copper(II) chloride | increases expression | ISO | RGD:1352146 | 6480464 | cupric chloride results in increased expression of MT2A mRNA | CTD | PMID:17211630 PMID:17409708 |
| copper(II) chloride | increases expression | ISO | RGD:1352146 | 6480464 | cupric chloride results in increased expression of MT2A mRNA | CTD | PMID:17409708 PMID:17211630 |
| copper(II) chloride | increases expression | ISO | RGD:1352146 | 6480464 | cupric chloride results in increased expression of MT2A mRNA | CTD | PMID:17409708 |
| coumarin | increases expression | EXP | | 6480464 | coumarin results in increased expression of MT2A mRNA | CTD | PMID:18480146 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of MT2A mRNA | CTD | PMID:20229497 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin affects the reaction [Mercuric Chloride results in increased expression of MT2A mRNA] | CTD | PMID:20229497 |
| cyclosporin A | increases expression | ISO | RGD:1352146 | 6480464 | Cyclosporine results in increased expression of MT2A mRNA | CTD | PMID:20106945 |
| cypermethrin | increases expression | ISO | RGD:1617617 | 6480464 | cypermethrin results in increased expression of MT2 mRNA | CTD | PMID:21142847 |
| cytarabine | decreases expression | ISO | RGD:1352146 | 6480464 | Cytarabine results in decreased expression of MT2A mRNA | CTD | PMID:21198554 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of MT2A mRNA | CTD | PMID:23056475 |
| D-glucose | multiple interactions | EXP | | 6480464 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glucose results in increased expression of MT2A mRNA]; more ... | CTD | PMID:23056475 |
| daidzein | increases expression | ISO | RGD:1352146 | 6480464 | daidzein results in increased expression of MT2A mRNA | CTD | PMID:10656621 |
| DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of MT2A mRNA | CTD | PMID:15885261 |
| DDT | multiple interactions | ISO | RGD:1352146 | 6480464 | MT2A protein inhibits the reaction [DDT results in decreased expression of HSD17B1 mRNA] | CTD | PMID:12858341 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:1617617 | 6480464 | Tetrahydrocannabinol results in increased expression of MT2 mRNA | CTD | PMID:21542829 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:1352146 | 6480464 | Tetrahydrocannabinol results in decreased expression of MT2A mRNA | CTD | PMID:18454173 |
| desferrioxamine B | multiple interactions | ISO | RGD:1352146 | 6480464 | [Deferoxamine results in decreased abundance of Iron] which results in increased expression of MT2A mRNA | CTD | PMID:12393473 |
| dexamethasone | multiple interactions | ISO | RGD:1617617 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MT2 mRNA | CTD | PMID:16054899 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of MT2A mRNA | CTD | PMID:15851833 |
| diarsenic trioxide | increases expression | ISO | RGD:1352146 | 6480464 | arsenic trioxide results in increased expression of MT2A mRNA | CTD | PMID:11678611 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1352146 | 6480464 | arsenic trioxide results in decreased expression of MT2A mRNA | CTD | PMID:22521957 |
| diarsenic trioxide | increases expression | ISO | RGD:1352146 | 6480464 | arsenic trioxide results in increased expression of MT2A mRNA | CTD | PMID:11678611 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:1352146 | 6480464 | arsenic trioxide results in increased expression of MT2A mRNA | CTD | PMID:11678611 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:1352146 | 6480464 | arsenic trioxide results in increased expression of MT2A mRNA | CTD | PMID:15725085 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:1352146 | 6480464 | arsenic trioxide results in increased expression of MT2A mRNA | CTD | PMID:19128835 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:1352146 | 6480464 | Atrazine promotes the reaction [arsenic trioxide results in increased expression of MT2A mRNA] | CTD | PMID:11678611 |
| diarsenic trioxide | increases expression | ISO | RGD:1352146 | 6480464 | arsenic trioxide results in increased expression of MT2A protein | CTD | PMID:14682389 |
| diarsenic trioxide | increases expression | ISO | RGD:1352146 | 6480464 | arsenic trioxide results in increased expression of MT2A mRNA | CTD | PMID:20458559 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:1352146 | 6480464 | arsenic trioxide results in increased expression of MT2A mRNA | CTD | PMID:11678611 more ... |
| diazoxide | increases expression | ISO | RGD:1617617 | 6480464 | Isoproterenol results in increased expression of MT2 mRNA | CTD | PMID:18089841 PMID:20003209 |
| diazoxide | increases expression | ISO | RGD:1617617 | 6480464 | Isoproterenol results in increased expression of MT2 mRNA | CTD | PMID:20003209 PMID:18089841 |
| diazoxide | multiple interactions | ISO | RGD:1617617 | 6480464 | Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MT2 mRNA] | CTD | PMID:18089841 |
| dibenzo[a,l]pyrene | multiple interactions | ISO | RGD:1352146 | 6480464 | [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] results in increased expression of MT2A mRNA | CTD | PMID:17690111 |
| diethyl maleate | increases expression | ISO | RGD:1352146 | 6480464 | diethyl maleate results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of MT2A mRNA | CTD | PMID:15890375 |
| dioxygen | increases expression | ISO | RGD:1352146 | 6480464 | Oxygen deficiency results in increased expression of MT2A mRNA | CTD | PMID:17914565 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of MT2A mRNA | CTD | PMID:17706837 PMID:19278353 |
| dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of MT2A mRNA | CTD | PMID:19278353 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of MT2A mRNA | CTD | PMID:19278353 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen results in increased expression of MT2A mRNA | CTD | PMID:15680347 |
| diphenylcyclopropenone | increases expression | ISO | RGD:1352146 | 6480464 | diphenylcyclopropenone results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| diquat | decreases expression | ISO | RGD:1617617 | 6480464 | Diquat results in decreased expression of MT2 mRNA | CTD | PMID:20826540 |
| diquat | multiple interactions | ISO | RGD:1617617 | 6480464 | PROP1 protein affects the reaction [Diquat results in decreased expression of MT2 mRNA] | CTD | PMID:20826540 |
| disulfiram | multiple interactions | ISO | RGD:1352146 | 6480464 | cupric chloride promotes the reaction [Disulfiram results in increased expression of MT2A mRNA] | CTD | PMID:19789329 |
| disulfiram | increases expression | ISO | RGD:1352146 | 6480464 | Disulfiram results in increased expression of MT2A mRNA | CTD | PMID:19789329 |
| dopamine | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 gene mutant form co-treated with MT2 gene mutant form co-treated with Mercuric Chloride] results in decreased abundance of Dopamine | CTD | PMID:18226494 |
| doxorubicin | decreases response to substance | ISO | RGD:1617617 | 6480464 | MT2A protein results in decreased susceptibility to Doxorubicin | CTD | PMID:16144979 PMID:9294117 |
| doxorubicin | decreases response to substance | ISO | RGD:1617617 | 6480464 | MT2 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:21463615 |
| doxorubicin | multiple interactions | ISO | RGD:1617617 | 6480464 | MT2 affects the reaction [Doxorubicin results in decreased expression of GPX1 protein]; more ... | CTD | PMID:21463615 |
| doxorubicin | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin | CTD | PMID:20600803 PMID:21040762 |
| doxorubicin | multiple interactions | ISO | RGD:1617617 | 6480464 | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of ADIPOQ mRNA; more ... | CTD | PMID:21040762 |
| doxorubicin | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 protein co-treated with MT2 protein] affects the reaction [Acetylcysteine affects the susceptibility to Doxorubicin]; more ... | CTD | PMID:20600803 |
| doxorubicin | decreases response to substance | ISO | RGD:1617617 | 6480464 | MT2A protein results in decreased susceptibility to Doxorubicin | CTD | PMID:9294117 PMID:16144979 |
| doxorubicin | multiple interactions | ISO | RGD:1617617 | 6480464 | [Doxorubicin co-treated with MT2A protein] results in decreased expression of ALDOART1 protein; more ... | CTD | PMID:16144979 |
| doxorubicin | decreases response to substance | ISO | RGD:1352146 | 6480464 | MT2A protein results in decreased susceptibility to Doxorubicin | CTD | PMID:11309296 |
| doxorubicin | increases expression | ISO | RGD:1352146 | 6480464 | Doxorubicin results in increased expression of MT2A mRNA | CTD | PMID:16579640 |
| doxorubicin | multiple interactions | ISO | RGD:1352146 | 6480464 | [Doxorubicin co-treated with pluronic block copolymer p85] results in increased expression of MT2A mRNA | CTD | PMID:16579640 |
| doxycycline | multiple interactions | ISO | RGD:1617617 | 6480464 | Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MT2 mRNA] | CTD | PMID:18089841 |
| ethanol | multiple interactions | EXP | | 6480464 | LEPR gene mutant form inhibits the reaction [Ethanol results in increased expression of MT2A mRNA] | CTD | PMID:15475485 |
| ethanol | increases expression | ISO | RGD:1617617 | 6480464 | Ethanol results in increased expression of MT2 mRNA | CTD | PMID:12658104 more ... |
| ethanol | increases expression | ISO | RGD:1617617 | 6480464 | Ethanol results in increased expression of MT2 mRNA | CTD | PMID:17637929 more ... |
| ethanol | increases expression | ISO | RGD:1617617 | 6480464 | Ethanol results in increased expression of MT2 mRNA | CTD | PMID:17637929 PMID:15513904 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of MT2A mRNA; more ... | CTD | PMID:17637929 |
| ethanol | increases expression | ISO | RGD:1617617 | 6480464 | Ethanol results in increased expression of MT2 mRNA | CTD | PMID:15513904 PMID:17637929 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of MT2A mRNA | CTD | PMID:15475485 PMID:17637929 |
| farnesal | increases expression | ISO | RGD:1352146 | 6480464 | farnesal results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| ferric ammonium citrate | multiple interactions | ISO | RGD:1352146 | 6480464 | [ferric ammonium citrate results in decreased abundance of Iron] which results in increased expression of MT2A mRNA | CTD | PMID:12393473 |
| fluorescein 5-isothiocyanate | increases expression | ISO | RGD:1352146 | 6480464 | Fluorescein-5-isothiocyanate results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of MT2A mRNA | CTD | PMID:15885261 |
| folic acid | multiple interactions | ISO | RGD:1617617 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MT2 mRNA | CTD | PMID:20938992 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of MT2A mRNA | CTD | PMID:21122807 |
| fructose | multiple interactions | EXP | | 6480464 | atorvastatin inhibits the reaction [Fructose results in increased expression of MT2A mRNA] | CTD | PMID:21122807 |
| fumonisin B1 | decreases expression | ISO | RGD:1617617 | 6480464 | fumonisin B1 results in decreased expression of MT2 mRNA | CTD | PMID:16221962 |
| genistein | increases expression | ISO | RGD:1352146 | 6480464 | Genistein results in increased expression of MT2A mRNA | CTD | PMID:10656621 |
| genistein 7-O-beta-D-glucoside | increases expression | ISO | RGD:1352146 | 6480464 | genistin analog results in increased expression of MT2A mRNA | CTD | PMID:16719502 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of MT2A mRNA | CTD | PMID:23056475 |
| glucose | multiple interactions | EXP | | 6480464 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glucose results in increased expression of MT2A mRNA]; more ... | CTD | PMID:23056475 |
| glutathione | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 protein co-treated with MT2 protein] affects the reaction [Glutathione affects the susceptibility to Doxorubicin] | CTD | PMID:20600803 |
| glycerol | increases expression | ISO | RGD:1352146 | 6480464 | Glycerol results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| hemin | multiple interactions | ISO | RGD:1352146 | 6480464 | [Hemin results in decreased abundance of Iron] which results in increased expression of MT2A mRNA | CTD | PMID:12393473 |
| hydrogen peroxide | increases expression | ISO | RGD:1352146 | 6480464 | Hydrogen Peroxide results in increased expression of MT2A mRNA | CTD | PMID:12414654 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 gene mutant form co-treated with MT2 gene mutant form] inhibits the reaction [Hydrogen Peroxide results in increased expression of ABCC1]; more ... | CTD | PMID:22914987 |
| hydrogen peroxide | increases expression | ISO | RGD:1617617 | 6480464 | Hydrogen Peroxide results in increased expression of MT2 mRNA | CTD | PMID:22914987 |
| hydrogen peroxide | affects expression | ISO | RGD:1352146 | 6480464 | Hydrogen Peroxide affects the expression of MT2A mRNA | CTD | PMID:21179406 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1352146 | 6480464 | MT2A protein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species] | CTD | PMID:19433272 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1617617 | 6480464 | [ferric nitrilotriacetate co-treated with Hydrogen Peroxide] inhibits the reaction [MT2 protein binds to Cadmium] | CTD | PMID:22001350 |
| hydrogen peroxide | increases expression | ISO | RGD:1617617 | 6480464 | Hydrogen Peroxide results in increased expression of MT2A mRNA | CTD | PMID:16972253 |
| hydroxycitronellal | increases expression | ISO | RGD:1352146 | 6480464 | hydroxycitronellal results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| iron atom | multiple interactions | EXP | | 6480464 | Iron results in increased expression of and affects the localization of MT2A protein; more ... | CTD | PMID:17241390 |
| iron atom | multiple interactions | ISO | RGD:1352146 | 6480464 | [Deferoxamine results in decreased abundance of Iron] which results in increased expression of MT2A mRNA; more ... | CTD | PMID:12393473 |
| iron atom | increases expression | EXP | | 6480464 | Iron deficiency results in increased expression of MT2A mRNA | CTD | PMID:16629162 |
| isoprenaline | multiple interactions | ISO | RGD:1617617 | 6480464 | Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MT2 mRNA] | CTD | PMID:18089841 |
| isoprenaline | increases expression | ISO | RGD:1617617 | 6480464 | Isoproterenol results in increased expression of MT2 mRNA | CTD | PMID:20003209 PMID:18089841 |
| isoprenaline | increases expression | ISO | RGD:1617617 | 6480464 | Isoproterenol results in increased expression of MT2 mRNA | CTD | PMID:18089841 PMID:20003209 |
| kaempferol | increases expression | ISO | RGD:1352146 | 6480464 | kaempferol results in increased expression of MT2A mRNA | CTD | PMID:10656621 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of MT2A mRNA | CTD | PMID:12692462 |
| kainic acid | decreases response to substance | ISO | RGD:1617617 | 6480464 | MT2 protein results in decreased susceptibility to Kainic Acid | CTD | PMID:10947810 |
| L-methionine | multiple interactions | ISO | RGD:1617617 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MT2 mRNA | CTD | PMID:20938992 |
| lead diacetate | multiple interactions | EXP | | 6480464 | lead acetate promotes the reaction [Cadmium Chloride results in increased expression of MT2A mRNA] | CTD | PMID:19096765 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of MT2A mRNA | CTD | PMID:22641619 |
| lead diacetate | increases expression | ISO | RGD:1617617 | 6480464 | lead acetate results in increased expression of MT2 mRNA | CTD | PMID:21335049 |
| lead diacetate | decreases response to substance | ISO | RGD:1617617 | 6480464 | MT2 results in decreased susceptibility to lead acetate | CTD | PMID:20600549 |
| LY294002 | multiple interactions | ISO | RGD:1352146 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Zinc results in increased expression of MT2A mRNA] | CTD | PMID:17363595 |
| malonaldehyde | increases expression | ISO | RGD:1352146 | 6480464 | Malondialdehyde results in increased expression of MT2A protein | CTD | PMID:15640275 |
| menadione | increases expression | ISO | RGD:1352146 | 6480464 | Vitamin K 3 results in increased expression of MT2A mRNA | CTD | PMID:12414654 |
| mercaptopurine | increases expression | EXP | | 6480464 | 6-Mercaptopurine results in increased expression of MT2A mRNA | CTD | PMID:23358152 |
| mercury atom | affects binding | ISO | RGD:1617617 | 6480464 | Mercury binds to MT2 protein | CTD | PMID:15603537 |
| mercury atom | increases expression | ISO | RGD:1617617 | 6480464 | Mercury results in increased expression of MT2 mRNA | CTD | PMID:17018868 PMID:21628964 |
| mercury atom | affects abundance | ISO | RGD:1352146 | 6480464 | MT2A gene SNP affects the abundance of Mercury | CTD | PMID:22233731 |
| mercury atom | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 co-treated with MT2] affects the susceptibility to Mercury | CTD | PMID:22008530 |
| mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of MT2A protein | CTD | PMID:12491035 |
| mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of MT2A | CTD | PMID:15138662 |
| mercury atom | increases response to substance | ISO | RGD:1617617 | 6480464 | MT2 gene mutant form results in increased susceptibility to Mercury | CTD | PMID:15782327 |
| mercury atom | increases expression | ISO | RGD:1617617 | 6480464 | Mercury results in increased expression of MT2 protein | CTD | PMID:15138662 |
| mercury atom | increases expression | ISO | RGD:1617617 | 6480464 | Mercury results in increased expression of MT2 mRNA | CTD | PMID:17018868 |
| mercury dichloride | increases expression | ISO | RGD:1352146 | 6480464 | Mercuric Chloride results in increased expression of MT2A mRNA | CTD | PMID:10362023 PMID:9138684 |
| mercury dichloride | increases expression | ISO | RGD:1617617 | 6480464 | Mercuric Chloride results in increased expression of MT2 mRNA | CTD | PMID:20450053 PMID:21628964 |
| mercury dichloride | affects expression | EXP | | 6480464 | Mercuric Chloride affects the expression of MT2A mRNA | CTD | PMID:10991963 |
| mercury dichloride | increases expression | ISO | RGD:1617617 | 6480464 | Mercuric Chloride results in increased expression of MT2 mRNA | CTD | PMID:21628964 |
| mercury dichloride | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 gene mutant form co-treated with MT2 gene mutant form] results in increased susceptibility to Mercuric Chloride; more ... | CTD | PMID:18226494 |
| mercury dichloride | multiple interactions | EXP | | 6480464 | Curcumin affects the reaction [Mercuric Chloride results in increased expression of MT2A mRNA] | CTD | PMID:20229497 |
| mercury dichloride | increases expression | EXP | | 6480464 | Mercuric Chloride results in increased expression of MT2A mRNA | CTD | PMID:20229497 |
| mercury dichloride | multiple interactions | ISO | RGD:1352146 | 6480464 | Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of MT2A mRNA] | CTD | PMID:9138684 |
| mercury(0) | affects binding | ISO | RGD:1617617 | 6480464 | Mercury binds to MT2 protein | CTD | PMID:15603537 |
| mercury(0) | increases expression | ISO | RGD:1617617 | 6480464 | Mercury results in increased expression of MT2 mRNA | CTD | PMID:17018868 PMID:21628964 |
| mercury(0) | affects abundance | ISO | RGD:1352146 | 6480464 | MT2A gene SNP affects the abundance of Mercury | CTD | PMID:22233731 |
| mercury(0) | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 co-treated with MT2] affects the susceptibility to Mercury | CTD | PMID:22008530 |
| mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of MT2A protein | CTD | PMID:12491035 |
| mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of MT2A | CTD | PMID:15138662 |
| mercury(0) | increases response to substance | ISO | RGD:1617617 | 6480464 | MT2 gene mutant form results in increased susceptibility to Mercury | CTD | PMID:15782327 |
| mercury(0) | increases expression | ISO | RGD:1617617 | 6480464 | Mercury results in increased expression of MT2 protein | CTD | PMID:15138662 |
| mercury(0) | increases expression | ISO | RGD:1617617 | 6480464 | Mercury results in increased expression of MT2 mRNA | CTD | PMID:17018868 |
| methamphetamine | increases expression | ISO | RGD:1352146 | 6480464 | Methamphetamine results in increased expression of MT2A mRNA | CTD | PMID:20801194 |
| methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of MT2A mRNA | CTD | PMID:15890375 |
| methoxychlor | multiple interactions | ISO | RGD:1352146 | 6480464 | MT2A protein inhibits the reaction [Methoxychlor results in decreased expression of HSD17B1 mRNA] | CTD | PMID:12858341 |
| methyl methanesulfonate | affects expression | EXP | | 6480464 | Methyl Methanesulfonate affects the expression of MT2A mRNA | CTD | PMID:12974610 |
| methyl non-2-ynoate | increases expression | ISO | RGD:1352146 | 6480464 | 2-nonynoic acid methyl ester results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| methylmercury chloride | increases expression | ISO | RGD:1617617 | 6480464 | methylmercuric chloride results in increased expression of MT2 mRNA | CTD | PMID:21628964 |
| microcystin-LR | increases expression | ISO | RGD:1617617 | 6480464 | cyanoginosin LR results in increased expression of MT2 mRNA | CTD | PMID:17654400 |
| mono(2-ethylhexyl) phthalate | affects expression | ISO | RGD:1617617 | 6480464 | mono-(2-ethylhexyl)phthalate affects the expression of MT2 mRNA | CTD | PMID:21195148 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1352146 | 6480464 | Acetylcysteine inhibits the reaction [Nickel results in increased expression of MT2A mRNA] | CTD | PMID:19097988 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 protein co-treated with MT2 protein] affects the reaction [Acetylcysteine affects the susceptibility to Doxorubicin] | CTD | PMID:20600803 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1352146 | 6480464 | Acetylcysteine inhibits the reaction [gallium nitrate results in increased expression of MT2A mRNA] | CTD | PMID:18586083 |
| N-nitrosodiethylamine | increases response to substance | ISO | RGD:1617617 | 6480464 | MT2 gene mutant form results in increased susceptibility to Diethylnitrosamine | CTD | PMID:21159647 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1352146 | 6480464 | Diethylnitrosamine results in increased expression of MT2A mRNA | CTD | PMID:21527772 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of MT2A mRNA | CTD | PMID:15890375 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of MT2 mRNA | CTD | PMID:14600272 |
| naphthalene | increases expression | ISO | RGD:1617617 | 6480464 | naphthalene results in increased expression of MT2 mRNA | CTD | PMID:18978301 |
| nickel atom | multiple interactions | ISO | RGD:1617617 | 6480464 | MT2 affects the reaction [Nickel affects the expression of CALR3 mRNA]; more ... | CTD | PMID:16166738 |
| nickel atom | increases expression | ISO | RGD:1352146 | 6480464 | Nickel results in increased expression of MT2A mRNA | CTD | PMID:19097988 PMID:14971665 |
| nickel atom | increases expression | ISO | RGD:1352146 | 6480464 | Nickel results in increased expression of MT2A protein | CTD | PMID:19097988 |
| nickel atom | increases expression | ISO | RGD:1352146 | 6480464 | Nickel results in increased expression of MT2A mRNA | CTD | PMID:14971665 PMID:19097988 |
| nickel atom | multiple interactions | ISO | RGD:1352146 | 6480464 | Acetylcysteine inhibits the reaction [Nickel results in increased expression of MT2A mRNA]; more ... | CTD | PMID:19097988 |
| nickel atom | increases response to substance | ISO | RGD:1617617 | 6480464 | MT2 gene mutant form results in increased susceptibility to Nickel | CTD | PMID:16166738 |
| nickel atom | decreases response to substance | ISO | RGD:1617617 | 6480464 | MT2 protein results in decreased susceptibility to Nickel | CTD | PMID:16166738 |
| nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of MT2A mRNA | CTD | PMID:22110744 |
| nickel sulfate | increases expression | ISO | RGD:1617617 | 6480464 | nickel sulfate results in increased expression of MT2 mRNA | CTD | PMID:19131640 PMID:16100012 |
| nickel sulfate | increases expression | ISO | RGD:1352146 | 6480464 | nickel sulfate results in increased expression of MT2A mRNA | CTD | PMID:16314067 PMID:20491607 |
| nickel sulfate | increases expression | ISO | RGD:1617617 | 6480464 | nickel sulfate results in increased expression of MT2 mRNA | CTD | PMID:16100012 PMID:19131640 |
| nickel sulfate | increases expression | ISO | RGD:1352146 | 6480464 | nickel sulfate results in increased expression of MT2A mRNA | CTD | PMID:16314067 |
| nitric oxide | multiple interactions | ISO | RGD:1617617 | 6480464 | Nitric Oxide affects the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of MT2 mRNA] | CTD | PMID:14617770 |
| nitroprusside | multiple interactions | ISO | RGD:1352146 | 6480464 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Nitroprusside results in increased expression of MT2A mRNA]; more ... | CTD | PMID:17018880 |
| nitroprusside | multiple interactions | ISO | RGD:1352146 | 6480464 | [Nitroprusside results in increased abundance of nitrosonium ion] which results in increased expression of MT2A mRNA | CTD | PMID:12393473 |
| nitroprusside | increases expression | ISO | RGD:1352146 | 6480464 | Nitroprusside results in increased expression of MT2A mRNA | CTD | PMID:17018880 |
| ochratoxin A | multiple interactions | ISO | RGD:1352146 | 6480464 | [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc co-treated with ochratoxin A] results in increased expression of MT2A mRNA; more ... | CTD | PMID:19720134 |
| ochratoxin A | increases expression | ISO | RGD:1352146 | 6480464 | ochratoxin A results in increased expression of MT2A mRNA | CTD | PMID:19720134 |
| oleanolic acid | increases expression | ISO | RGD:1617617 | 6480464 | Oleanolic Acid results in increased expression of MT2 mRNA | CTD | PMID:18706400 PMID:17637929 |
| oleanolic acid | increases expression | ISO | RGD:1617617 | 6480464 | Oleanolic Acid results in increased expression of MT2 mRNA | CTD | PMID:17637929 PMID:18706400 |
| oleanolic acid | increases expression | EXP | | 6480464 | Oleanolic Acid results in increased expression of MT2 mRNA | CTD | PMID:18706400 |
| oleanolic acid | increases expression | EXP | | 6480464 | Oleanolic Acid results in increased expression of MT2A mRNA; more ... | CTD | PMID:17637929 |
| oxaliplatin | decreases expression | ISO | RGD:1352146 | 6480464 | oxaliplatin results in decreased expression of MT2A mRNA | CTD | PMID:16773204 |
| oxaliplatin | affects response to substance | ISO | RGD:1352146 | 6480464 | MT2A protein affects the susceptibility to oxaliplatin | CTD | PMID:16773204 |
| ozone | multiple interactions | ISO | RGD:1617617 | 6480464 | MT2 protein affects the reaction [Ozone affects the expression of HMOX1 protein]; more ... | CTD | PMID:18929643 |
| ozone | increases expression | ISO | RGD:1617617 | 6480464 | Ozone results in increased expression of MT2 mRNA | CTD | PMID:12763052 more ... |
| ozone | increases expression | ISO | RGD:1617617 | 6480464 | Ozone results in increased expression of MT2 mRNA | CTD | PMID:20417186 more ... |
| ozone | increases expression | ISO | RGD:1617617 | 6480464 | Ozone results in increased expression of MT2 mRNA | CTD | PMID:12763052 more ... |
| ozone | increases expression | ISO | RGD:1617617 | 6480464 | Ozone results in increased expression of MT2 mRNA | CTD | PMID:20417186 more ... |
| ozone | increases expression | ISO | RGD:1617617 | 6480464 | Ozone results in increased expression of MT2 mRNA | CTD | PMID:12763052 more ... |
| ozone | increases expression | ISO | RGD:1617617 | 6480464 | Ozone results in increased expression of MT2 protein | CTD | PMID:18929643 |
| ozone | increases expression | ISO | RGD:1617617 | 6480464 | Ozone results in increased expression of MT2 mRNA | CTD | PMID:17460151 more ... |
| ozone | affects response to substance | ISO | RGD:1617617 | 6480464 | MT2 protein affects the susceptibility to Ozone | CTD | PMID:18929643 |
| ozone | multiple interactions | ISO | RGD:1617617 | 6480464 | GCLM gene mutant form promotes the reaction [Ozone results in increased expression of MT2 mRNA] | CTD | PMID:20417186 |
| paclitaxel | increases response to substance | ISO | RGD:1352146 | 6480464 | MT2A mRNA results in increased susceptibility to Paclitaxel | CTD | PMID:16322897 |
| palmitic acid | decreases expression | ISO | RGD:1352146 | 6480464 | Palmitic Acid results in decreased expression of MT2A mRNA | CTD | PMID:17658692 |
| paracetamol | multiple interactions | ISO | RGD:1617617 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of MT2 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | affects expression | ISO | RGD:1617617 | 6480464 | Acetaminophen affects the expression of MT2 mRNA | CTD | PMID:17562736 PMID:15606129 |
| paracetamol | affects expression | ISO | RGD:1617617 | 6480464 | Acetaminophen affects the expression of MT2 mRNA | CTD | PMID:15606129 PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1617617 | 6480464 | Acetaminophen results in increased expression of MT2 mRNA | CTD | PMID:11264010 |
| paraquat | increases expression | ISO | RGD:1617617 | 6480464 | Paraquat results in increased expression of MT2 mRNA | CTD | PMID:12595580 PMID:17215068 |
| paraquat | multiple interactions | EXP | | 6480464 | Paraquat promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA]; more ... | CTD | PMID:20553223 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of MT2A mRNA | CTD | PMID:20553223 |
| paraquat | increases expression | ISO | RGD:1617617 | 6480464 | Paraquat results in increased expression of MT2 mRNA | CTD | PMID:17215068 PMID:12595580 |
| paraquat | increases expression | ISO | RGD:1352146 | 6480464 | Paraquat results in increased expression of MT2A mRNA | CTD | PMID:14503839 |
| parathion | multiple interactions | ISO | RGD:1352146 | 6480464 | [Parathion co-treated with Estradiol] results in decreased expression of MT2A mRNA | CTD | PMID:17982697 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:1617617 | 6480464 | perfluorooctanoic acid results in decreased expression of MT2 mRNA | CTD | PMID:20118188 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:1617617 | 6480464 | PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of MT2 mRNA] | CTD | PMID:20118188 |
| phenobarbital | multiple interactions | ISO | RGD:1617617 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MT2 mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:1617617 | 6480464 | Phenobarbital affects the expression of MT2 mRNA | CTD | PMID:23091169 |
| phenobarbital | decreases expression | ISO | RGD:1617617 | 6480464 | Phenobarbital results in decreased expression of MT2 mRNA | CTD | PMID:19270015 PMID:19850644 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of MT2A mRNA | CTD | PMID:19162173 |
| phenobarbital | increases expression | ISO | RGD:1617617 | 6480464 | Phenobarbital results in increased expression of MT2 mRNA | CTD | PMID:19482888 |
| phenobarbital | decreases expression | ISO | RGD:1617617 | 6480464 | Phenobarbital results in decreased expression of MT2 mRNA | CTD | PMID:19850644 PMID:19270015 |
| phenobarbital | multiple interactions | ISO | RGD:1617617 | 6480464 | NR1I3 protein promotes the reaction [Phenobarbital results in decreased expression of MT2 mRNA] | CTD | PMID:19850644 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1352146 | 6480464 | [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MT2A mRNA | CTD | PMID:18958680 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1352146 | 6480464 | BAG1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MT2A mRNA] | CTD | PMID:20858459 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1352146 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MT2A mRNA | CTD | PMID:20858459 |
| phorbol 13-acetate 12-myristate | increases response to substance | ISO | RGD:1617617 | 6480464 | MT2 results in increased susceptibility to Tetradecanoylphorbol Acetate | CTD | PMID:9506445 |
| phosgene | affects expression | ISO | RGD:1617617 | 6480464 | Phosgene affects the expression of MT2 mRNA | CTD | PMID:16300373 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of MT2A mRNA | CTD | PMID:15890375 |
| pirinixic acid | affects expression | ISO | RGD:1617617 | 6480464 | pirinixic acid affects the expression of MT2 mRNA | CTD | PMID:11798191 PMID:19850644 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of MT2A mRNA | CTD | PMID:15890375 PMID:19162173 |
| pirinixic acid | decreases expression | ISO | RGD:1617617 | 6480464 | pirinixic acid results in decreased expression of MT2 mRNA | CTD | PMID:17321000 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1617617 | 6480464 | pirinixic acid results in decreased expression of MT2 mRNA | CTD | PMID:17321000 more ... |
| pirinixic acid | increases expression | ISO | RGD:1617617 | 6480464 | pirinixic acid results in increased expression of MT2 mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:1617617 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of MT2 mRNA] | CTD | PMID:20059764 PMID:19850644 |
| pirinixic acid | increases expression | ISO | RGD:1617617 | 6480464 | pirinixic acid results in increased expression of MT2 mRNA | CTD | PMID:18445702 more ... |
| pirinixic acid | increases expression | ISO | RGD:1617617 | 6480464 | pirinixic acid results in increased expression of MT2 mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1617617 | 6480464 | pirinixic acid results in decreased expression of MT2 mRNA | CTD | PMID:20059764 more ... |
| pirinixic acid | affects expression | ISO | RGD:1617617 | 6480464 | pirinixic acid affects the expression of MT2 mRNA | CTD | PMID:19850644 PMID:11798191 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of MT2A mRNA | CTD | PMID:19162173 PMID:15890375 |
| pirinixic acid | multiple interactions | ISO | RGD:1617617 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of MT2 mRNA] | CTD | PMID:19850644 PMID:20059764 |
| pirinixic acid | increases expression | ISO | RGD:1617617 | 6480464 | pirinixic acid results in increased expression of MT2 mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:1617617 | 6480464 | PPARA protein affects the reaction [pirinixic acid results in decreased expression of MT2 mRNA] | CTD | PMID:17321000 |
| pirinixic acid | decreases expression | ISO | RGD:1617617 | 6480464 | pirinixic acid results in decreased expression of MT2 mRNA | CTD | PMID:20813756 more ... |
| piroxicam | decreases expression | ISO | RGD:1352146 | 6480464 | Piroxicam results in decreased expression of MT2A mRNA | CTD | PMID:21858171 |
| progesterone | affects expression | ISO | RGD:1617617 | 6480464 | Progesterone affects the expression of MT2 mRNA | CTD | PMID:17251523 |
| progesterone | increases expression | ISO | RGD:1352146 | 6480464 | Progesterone results in increased expression of MT2A mRNA | CTD | PMID:18037150 |
| propiconazole | increases expression | ISO | RGD:1617617 | 6480464 | propiconazole results in increased expression of MT2 mRNA | CTD | PMID:22334560 |
| purine-6-thiol | increases expression | EXP | | 6480464 | 6-Mercaptopurine results in increased expression of MT2A mRNA | CTD | PMID:23358152 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [Cadmium results in increased expression of MT2 mRNA] | CTD | PMID:16226777 |
| quercetin | increases expression | ISO | RGD:1352146 | 6480464 | Quercetin results in increased expression of MT2A mRNA | CTD | PMID:10656621 PMID:21632981 |
| quercetin | affects expression | EXP | | 6480464 | Quercetin affects the expression of MT2A mRNA | CTD | PMID:18178720 |
| quercetin | increases expression | ISO | RGD:1352146 | 6480464 | Quercetin results in increased expression of MT2A mRNA | CTD | PMID:10656621 |
| raloxifene | increases expression | ISO | RGD:1352146 | 6480464 | Raloxifene results in increased expression of MT2A mRNA | CTD | PMID:20945400 |
| rosiglitazone | multiple interactions | ISO | RGD:1617617 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MT2 mRNA | CTD | PMID:16054899 |
| rotenone | multiple interactions | EXP | | 6480464 | GPX4 protein inhibits the reaction [Rotenone results in increased expression of MT2 mRNA] | CTD | PMID:19818760 |
| rotenone | increases expression | ISO | RGD:1352146 | 6480464 | Rotenone results in increased expression of MT2A mRNA | CTD | PMID:16402917 |
| rotenone | multiple interactions | ISO | RGD:1352146 | 6480464 | MT2A protein inhibits the reaction [Rotenone results in increased activity of CASP3 protein]; more ... | CTD | PMID:16402917 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of MT2 mRNA | CTD | PMID:19818760 |
| serotonin | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 gene mutant form co-treated with MT2 gene mutant form] results in increased abundance of Serotonin | CTD | PMID:18226494 |
| silver atom | increases expression | ISO | RGD:1352146 | 6480464 | Silver results in increased expression of MT2A mRNA | CTD | PMID:22079246 |
| silver atom | increases expression | ISO | RGD:1352146 | 6480464 | Silver results in increased expression of MT2A mRNA | CTD | PMID:22036727 PMID:22546375 |
| silver atom | increases expression | ISO | RGD:1352146 | 6480464 | Silver results in increased expression of MT2A mRNA | CTD | PMID:22036727 |
| silver(0) | increases expression | ISO | RGD:1352146 | 6480464 | Silver results in increased expression of MT2A mRNA | CTD | PMID:22079246 |
| silver(0) | increases expression | ISO | RGD:1352146 | 6480464 | Silver results in increased expression of MT2A mRNA | CTD | PMID:22036727 PMID:22546375 |
| silver(0) | increases expression | ISO | RGD:1352146 | 6480464 | Silver results in increased expression of MT2A mRNA | CTD | PMID:22036727 |
| silver(1+) nitrate | increases expression | ISO | RGD:1352146 | 6480464 | Silver Nitrate results in increased expression of MT2A mRNA | CTD | PMID:10362023 PMID:20491607 |
| silver(1+) nitrate | increases expression | ISO | RGD:1352146 | 6480464 | Silver Nitrate results in increased expression of MT2A mRNA | CTD | PMID:10362023 more ... |
| silver(1+) nitrate | increases expression | ISO | RGD:1352146 | 6480464 | Silver Nitrate results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of MT2A mRNA | CTD | PMID:22110744 |
| sodium dichromate | increases expression | ISO | RGD:1617617 | 6480464 | sodium bichromate results in increased expression of MT2 mRNA | CTD | PMID:22155349 |
| sodium dichromate | decreases expression | ISO | RGD:1617617 | 6480464 | sodium bichromate results in decreased expression of MT2 mRNA | CTD | PMID:22155349 |
| sulforaphane | increases expression | ISO | RGD:1352146 | 6480464 | sulforafan results in increased expression of MT2A protein; more ... | CTD | PMID:16033772 |
| tamoxifen | affects expression | ISO | RGD:1617617 | 6480464 | Tamoxifen affects the expression of MT2 mRNA | CTD | PMID:20937368 |
| temozolomide | affects response to substance | ISO | RGD:1352146 | 6480464 | MT2A mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| terbutaline | multiple interactions | ISO | RGD:1352146 | 6480464 | Terbutaline affects the reaction [Budesonide results in increased expression of MT2A mRNA] | CTD | PMID:9973176 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1352146 | 6480464 | tert-Butylhydroperoxide results in increased expression of MT2A mRNA | CTD | PMID:16636651 more ... |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1352146 | 6480464 | tert-Butylhydroperoxide results in increased expression of MT2A mRNA | CTD | PMID:12414654 more ... |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1352146 | 6480464 | tert-Butylhydroperoxide results in increased expression of MT2A mRNA | CTD | PMID:12414654 more ... |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1352146 | 6480464 | tert-Butylhydroperoxide results in increased expression of MT2A mRNA | CTD | PMID:16402917 more ... |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1352146 | 6480464 | tert-Butylhydroperoxide results in increased expression of MT2A mRNA | CTD | PMID:16402917 more ... |
| tert-butyl hydroperoxide | decreases response to substance | ISO | RGD:1352146 | 6480464 | MT2A protein results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:16636651 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:1352146 | 6480464 | MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; more ... | CTD | PMID:16636651 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:1352146 | 6480464 | MT2A protein inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species] | CTD | PMID:16402917 |
| tert-butyl hydroperoxide | decreases response to substance | ISO | RGD:1617617 | 6480464 | MT2 protein results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:16150881 |
| tetrachloromethane | increases expression | ISO | RGD:1617617 | 6480464 | Carbon Tetrachloride results in increased expression of MT2 protein | CTD | PMID:20371262 |
| thapsigargin | increases expression | ISO | RGD:1617617 | 6480464 | Thapsigargin results in increased expression of MT2 mRNA | CTD | PMID:15019097 |
| thimerosal | increases expression | ISO | RGD:1617617 | 6480464 | Thimerosal results in increased expression of MT2 mRNA; more ... | CTD | PMID:19357975 |
| thioacetamide | affects response to substance | ISO | RGD:1617617 | 6480464 | MT2 protein affects the susceptibility to Thioacetamide | CTD | PMID:15979673 |
| thioacetamide | increases expression | ISO | RGD:1617617 | 6480464 | Thioacetamide results in increased expression of MT2 protein | CTD | PMID:15979673 |
| troglitazone | increases expression | ISO | RGD:1352146 | 6480464 | troglitazone results in increased expression of MT2A mRNA | CTD | PMID:19631733 |
| tunicamycin | increases expression | ISO | RGD:1617617 | 6480464 | Tunicamycin results in increased expression of MT2 mRNA | CTD | PMID:15019097 PMID:17127020 |
| tunicamycin | increases expression | ISO | RGD:1617617 | 6480464 | Tunicamycin results in increased expression of MT2 mRNA | CTD | PMID:17127020 PMID:15019097 |
| uranium atom | increases expression | ISO | RGD:1352146 | 6480464 | Uranium results in increased expression of MT2A mRNA | CTD | PMID:14971665 |
| ursodeoxycholic acid | increases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in increased expression of MT2A mRNA | CTD | PMID:10491327 |
| valproic acid | increases expression | ISO | RGD:1617617 | 6480464 | Valproic Acid results in increased expression of MT2 mRNA | CTD | PMID:15345369 |
| valproic acid | increases expression | ISO | RGD:1617617 | 6480464 | Valproic Acid results in increased expression of MT2 mRNA | CTD | PMID:19136453 PMID:15345369 |
| valproic acid | increases expression | ISO | RGD:1617617 | 6480464 | Valproic Acid results in increased expression of MT2 mRNA | CTD | PMID:15345369 PMID:19136453 |
| valproic acid | increases expression | ISO | RGD:1352146 | 6480464 | Valproic Acid results in increased expression of MT2A mRNA | CTD | PMID:19101580 |
| vancomycin | decreases expression | ISO | RGD:1617617 | 6480464 | Vancomycin results in decreased expression of MT2 mRNA | CTD | PMID:18930951 |
| vanillin | increases expression | ISO | RGD:1352146 | 6480464 | vanillin results in increased expression of MT2A mRNA | CTD | PMID:20491607 |
| zidovudine | multiple interactions | ISO | RGD:1352146 | 6480464 | [Zidovudine co-treated with IFNA1 protein] results in increased expression of MT2A mRNA | CTD | PMID:20370541 |
| zinc atom | affects binding | ISO | RGD:1617617 | 6480464 | Zinc binds to MT2 protein | CTD | PMID:16987576 |
| zinc atom | affects transport | ISO | RGD:1617617 | 6480464 | MT2 protein affects the transport of Zinc | CTD | PMID:23274088 |
| zinc atom | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:11127411 more ... |
| zinc atom | multiple interactions | ISO | RGD:1352146 | 6480464 | Zinc promotes the reaction [IL1B protein results in increased expression of MT2A mRNA]; more ... | CTD | PMID:1502195 |
| zinc atom | multiple interactions | ISO | RGD:1352146 | 6480464 | CEBPA protein inhibits the reaction [Zinc results in increased expression of MT2A mRNA] | CTD | PMID:15389791 |
| zinc atom | multiple interactions | EXP | | 6480464 | SLC30A1 protein promotes the reaction [[MT1 protein co-treated with MT2 protein] inhibits the reaction [SLC30A1 gene mutant form results in increased susceptibility to Zinc]] | CTD | PMID:15041749 |
| zinc atom | multiple interactions | ISO | RGD:1617617 | 6480464 | MT2 gene mutant form inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] affects the localization of Zinc] | CTD | PMID:14617770 |
| zinc atom | increases expression | ISO | RGD:1617617 | 6480464 | Zinc results in increased expression of MT2 mRNA | CTD | PMID:10605938 more ... |
| zinc atom | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 protein co-treated with MT2 protein] inhibits the reaction [SLC30A1 gene mutant form results in increased susceptibility to Zinc]; more ... | CTD | PMID:15041749 |
| zinc atom | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2 mRNA | CTD | PMID:2173694 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of MT2A mRNA | CTD | PMID:12672911 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of MT2A | CTD | PMID:20128680 |
| zinc atom | multiple interactions | ISO | RGD:1352146 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of MT2A mRNA | CTD | PMID:18593933 |
| zinc atom | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:11127411 more ... |
| zinc atom | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:17409696 more ... |
| zinc atom | increases expression | ISO | RGD:1617617 | 6480464 | Zinc results in increased expression of MT2 mRNA | CTD | PMID:10605938 PMID:11525245 |
| zinc atom | multiple interactions | ISO | RGD:1617617 | 6480464 | cerous chloride promotes the reaction [Zinc binds to MT2 protein] | CTD | PMID:16204935 |
| zinc atom | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [Cadmium Chloride results in increased expression of MT2A] | CTD | PMID:20096345 |
| zinc atom | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:16870260 more ... |
| zinc atom | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:12716893 more ... |
| zinc atom | multiple interactions | ISO | RGD:1352146 | 6480464 | [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc co-treated with ochratoxin A] results in increased expression of MT2A mRNA; more ... | CTD | PMID:19720134 |
| zinc atom | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:11127411 more ... |
| zinc atom | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:17409708 more ... |
| zinc atom | affects binding | ISO | RGD:1352146 | 6480464 | Zinc binds to MT2A protein | CTD | PMID:17224279 PMID:15698955 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:17241390 |
| zinc atom | affects expression | EXP | | 6480464 | Zinc affects the expression of MT2A mRNA | CTD | PMID:14690761 |
| zinc atom | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Iron] results in increased expression of and affects the localization of MT2A protein; more ... | CTD | PMID:17241390 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:15612480 |
| zinc atom | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:11168427 more ... |
| zinc atom | multiple interactions | ISO | RGD:1352146 | 6480464 | Zinc promotes the reaction [MTF1 protein binds to MT2A enhancer] | CTD | PMID:16460681 |
| zinc atom | affects binding | ISO | RGD:1352146 | 6480464 | Zinc binds to MT2A protein | CTD | PMID:15698955 PMID:17224279 |
| zinc atom | multiple interactions | ISO | RGD:1352146 | 6480464 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of MT2A mRNA] | CTD | PMID:19097988 |
| zinc atom | multiple interactions | ISO | RGD:1352146 | 6480464 | chromium hexavalent ion inhibits the reaction [Zinc results in increased expression of MT2A mRNA] | CTD | PMID:12716893 |
| zinc atom | multiple interactions | ISO | RGD:1352146 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Zinc results in increased expression of MT2A mRNA]; more ... | CTD | PMID:17363595 |
| zinc atom | increases expression | ISO | RGD:1617617 | 6480464 | Zinc results in increased expression of MT2 mRNA | CTD | PMID:11525245 |
| zinc dichloride | affects binding | ISO | RGD:1617617 | 6480464 | zinc chloride binds to MT2 protein | CTD | PMID:16987576 |
| zinc dichloride | multiple interactions | EXP | | 6480464 | zinc chloride promotes the reaction [Glucose results in increased expression of MT2A mRNA] | CTD | PMID:23056475 |
| zinc dichloride | multiple interactions | ISO | RGD:1352146 | 6480464 | zinc chloride inhibits the reaction [Lipopolysaccharides results in increased expression of MT2A mRNA] | CTD | PMID:9138684 |
| zinc dichloride | increases expression | ISO | RGD:1352146 | 6480464 | zinc chloride results in increased expression of MT2A mRNA | CTD | PMID:16870260 more ... |
| zinc dichloride | increases expression | ISO | RGD:1352146 | 6480464 | zinc chloride results in increased expression of MT2A mRNA | CTD | PMID:16870260 more ... |
| zinc dichloride | multiple interactions | ISO | RGD:1352146 | 6480464 | [zinc chloride co-treated with pyrithione zinc] results in increased expression of MT2A mRNA | CTD | PMID:20801194 |
| zinc dichloride | multiple interactions | ISO | RGD:1352146 | 6480464 | Dactinomycin inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA] | CTD | PMID:17234632 |
| zinc dichloride | increases expression | ISO | RGD:1617617 | 6480464 | zinc chloride results in increased expression of MT2 mRNA | CTD | PMID:17637929 PMID:19835899 |
| zinc dichloride | affects response to substance | ISO | RGD:1617617 | 6480464 | MT2 affects the susceptibility to zinc chloride | CTD | PMID:19835899 |
| zinc dichloride | increases expression | ISO | RGD:1352146 | 6480464 | zinc chloride results in increased expression of MT2A mRNA | CTD | PMID:16870260 PMID:20471814 |
| zinc dichloride | multiple interactions | ISO | RGD:1617617 | 6480464 | zinc chloride promotes the reaction [Cadmium Chloride results in increased expression of MT2 mRNA] | CTD | PMID:16842966 |
| zinc dichloride | increases expression | ISO | RGD:1352146 | 6480464 | zinc chloride results in increased expression of MT2A mRNA | CTD | PMID:20471814 PMID:16870260 |
| zinc dichloride | multiple interactions | ISO | RGD:1352146 | 6480464 | Grape Seed Proanthocyanidins inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA]; more ... | CTD | PMID:20471814 |
| zinc dichloride | increases expression | EXP | | 6480464 | zinc chloride results in increased expression of MT2A mRNA; more ... | CTD | PMID:17637929 |
| zinc dichloride | increases expression | ISO | RGD:1352146 | 6480464 | zinc chloride results in increased expression of MT2A mRNA | CTD | PMID:16870260 |
| zinc dichloride | increases expression | ISO | RGD:1617617 | 6480464 | zinc chloride results in increased expression of MT2 protein | CTD | PMID:15288509 |
| zinc dichloride | increases expression | ISO | RGD:1617617 | 6480464 | zinc chloride results in increased expression of MT2 mRNA | CTD | PMID:17637929 |
| zinc pyrithione | increases expression | ISO | RGD:1352146 | 6480464 | zinc pyrithione results in increased expression of MT2A mRNA | CTD | PMID:21424779 |
| zinc sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Zinc Sulfate results in increased expression of MT2A mRNA | CTD | PMID:17018880 more ... |
| zinc sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Zinc Sulfate results in increased expression of MT2A mRNA | CTD | PMID:10362023 more ... |
| zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of MT2A mRNA | CTD | PMID:17241390 PMID:20553223 |
| zinc sulfate | multiple interactions | EXP | | 6480464 | Zinc Sulfate promotes the reaction [Paraquat results in increased expression of MT2A mRNA]; more ... | CTD | PMID:20553223 |
| zinc sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Zinc Sulfate results in increased expression of MT2A mRNA | CTD | PMID:12566070 more ... |
| zinc sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Zinc Sulfate results in increased expression of MT2A mRNA | CTD | PMID:17018880 more ... |
| zinc sulfate | multiple interactions | ISO | RGD:1352146 | 6480464 | Arachidonic Acid promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA] | CTD | PMID:12566070 |
| zinc sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Zinc Sulfate results in increased expression of MT2A mRNA | CTD | PMID:15226459 more ... |
| zinc sulfate | multiple interactions | ISO | RGD:1352146 | 6480464 | PTEN promotes the reaction [Zinc Sulfate results in increased expression of MT2A mRNA] | CTD | PMID:21883094 |
| zinc sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Zinc Sulfate results in increased expression of MT2A mRNA | CTD | PMID:17409708 more ... |
| zinc sulfate | increases expression | ISO | RGD:1352146 | 6480464 | Zinc Sulfate results in increased expression of MT2A mRNA | CTD | PMID:15226459 more ... |
| zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of MT2A mRNA | CTD | PMID:17241390 |
| zinc sulfate | multiple interactions | EXP | | 6480464 | [Zinc Sulfate co-treated with ferrous sulfate] results in increased expression of and affects the localization of MT2A protein; more ... | CTD | PMID:17241390 |
| zinc sulfate | multiple interactions | ISO | RGD:1352146 | 6480464 | Zinc Sulfate promotes the reaction [MTF1 protein binds to MT2A enhancer] | CTD | PMID:16460681 |
| zinc sulfate | multiple interactions | ISO | RGD:1352146 | 6480464 | Zinc Sulfate promotes the reaction [Nitroprusside results in increased expression of MT2A mRNA] | CTD | PMID:17018880 |
| zinc(0) | affects binding | ISO | RGD:1617617 | 6480464 | Zinc binds to MT2 protein | CTD | PMID:16987576 |
| zinc(0) | increases expression | ISO | RGD:1617617 | 6480464 | Zinc results in increased expression of MT2 mRNA | CTD | PMID:11525245 |
| zinc(0) | multiple interactions | ISO | RGD:1352146 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Zinc results in increased expression of MT2A mRNA]; more ... | CTD | PMID:17363595 |
| zinc(0) | multiple interactions | ISO | RGD:1352146 | 6480464 | chromium hexavalent ion inhibits the reaction [Zinc results in increased expression of MT2A mRNA] | CTD | PMID:12716893 |
| zinc(0) | multiple interactions | ISO | RGD:1352146 | 6480464 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of MT2A mRNA] | CTD | PMID:19097988 |
| zinc(0) | affects binding | ISO | RGD:1352146 | 6480464 | Zinc binds to MT2A protein | CTD | PMID:15698955 PMID:17224279 |
| zinc(0) | multiple interactions | ISO | RGD:1352146 | 6480464 | Zinc promotes the reaction [MTF1 protein binds to MT2A enhancer] | CTD | PMID:16460681 |
| zinc(0) | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:11168427 more ... |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:15612480 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Iron] results in increased expression of and affects the localization of MT2A protein; more ... | CTD | PMID:17241390 |
| zinc(0) | affects expression | EXP | | 6480464 | Zinc affects the expression of MT2A mRNA | CTD | PMID:14690761 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:17241390 |
| zinc(0) | affects binding | ISO | RGD:1352146 | 6480464 | Zinc binds to MT2A protein | CTD | PMID:17224279 PMID:15698955 |
| zinc(0) | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:17409708 more ... |
| zinc(0) | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:11127411 more ... |
| zinc(0) | multiple interactions | ISO | RGD:1352146 | 6480464 | [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Zinc co-treated with ochratoxin A] results in increased expression of MT2A mRNA; more ... | CTD | PMID:19720134 |
| zinc(0) | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:12716893 more ... |
| zinc(0) | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:16870260 more ... |
| zinc(0) | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [Cadmium Chloride results in increased expression of MT2A] | CTD | PMID:20096345 |
| zinc(0) | multiple interactions | ISO | RGD:1617617 | 6480464 | cerous chloride promotes the reaction [Zinc binds to MT2 protein] | CTD | PMID:16204935 |
| zinc(0) | increases expression | ISO | RGD:1617617 | 6480464 | Zinc results in increased expression of MT2 mRNA | CTD | PMID:10605938 PMID:11525245 |
| zinc(0) | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:17409696 more ... |
| zinc(0) | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:11127411 more ... |
| zinc(0) | multiple interactions | ISO | RGD:1352146 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of MT2A mRNA | CTD | PMID:18593933 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of MT2A | CTD | PMID:20128680 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of MT2A mRNA | CTD | PMID:12672911 |
| zinc(0) | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2 mRNA | CTD | PMID:2173694 |
| zinc(0) | multiple interactions | ISO | RGD:1617617 | 6480464 | [MT1 protein co-treated with MT2 protein] inhibits the reaction [SLC30A1 gene mutant form results in increased susceptibility to Zinc]; more ... | CTD | PMID:15041749 |
| zinc(0) | increases expression | ISO | RGD:1617617 | 6480464 | Zinc results in increased expression of MT2 mRNA | CTD | PMID:10605938 more ... |
| zinc(0) | multiple interactions | ISO | RGD:1617617 | 6480464 | MT2 gene mutant form inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] affects the localization of Zinc] | CTD | PMID:14617770 |
| zinc(0) | multiple interactions | EXP | | 6480464 | SLC30A1 protein promotes the reaction [[MT1 protein co-treated with MT2 protein] inhibits the reaction [SLC30A1 gene mutant form results in increased susceptibility to Zinc]] | CTD | PMID:15041749 |
| zinc(0) | multiple interactions | ISO | RGD:1352146 | 6480464 | CEBPA protein inhibits the reaction [Zinc results in increased expression of MT2A mRNA] | CTD | PMID:15389791 |
| zinc(0) | multiple interactions | ISO | RGD:1352146 | 6480464 | Zinc promotes the reaction [IL1B protein results in increased expression of MT2A mRNA]; more ... | CTD | PMID:1502195 |
| zinc(0) | increases expression | ISO | RGD:1352146 | 6480464 | Zinc results in increased expression of MT2A mRNA | CTD | PMID:11127411 more ... |
| zinc(0) | affects transport | ISO | RGD:1617617 | 6480464 | MT2 protein affects the transport of Zinc | CTD | PMID:23274088 |